▉ Introduction Antibody-drug conjugates (ADCs) are currently developing rapidly, utilizing antibodies to selectively deliver cytotoxic drugs to tumor sites. As of May 2021, the U.S. Food and Drug Administration (FDA) has approved 10 ADCs, including Adcetris®, Kadcyla®, Besponsa®, Mylotarg®, Polivy®, Padcev®, Enhertu®, Trodvy®, Blenrep®, and Zynlonta™ for use as monotherapy or in combination for the … Read more
Source: Wang Xin, Rao Benqiang. High-Dose Vitamin C Precision Therapy for Tumors [J/CD]. Journal of Tumor Metabolism and Nutrition, 2023, 10(3): 307-312. Article link: http://182.92.200.144/CN/abstract/abstract1016.shtml Expert Introduction Rao Benqiang, Deputy Director of the Second Department of Gastrointestinal Surgery at Beijing Shijitan Hospital, Capital Medical University, Deputy Director of the National Market Supervision Key Laboratory (Tumor … Read more
Fu Rui Sen Na Mi N A N O NIR-Ⅱ FLI Thiophene π-Bridge Manipulation of NIR-II AIEgens for Multimodal Tumor Phototheranostics Journal:Angewandte Chemie-International Edition, IF=16.1 Pub Date:2024-02-12 First Author:Yixiong Gui, Yuanwei Wang, Deliang Wang Corresponding Authors:Dingyuan Yan*, Ben Zhong Tang*, and Dong Wang* Corresponding Author Institution: School of Science and Engineering, Shenzhen Institute of Aggregate … Read more